期刊文献+

sCD40L联合长春瑞滨对肺腺癌A549细胞的作用 被引量:4

Effect of sCD40L Combined with Vinorelbine on Lung Adenocarcinoma Cell A549
下载PDF
导出
摘要 背景与目的CD40信号对肿瘤细胞化疗敏感性的影响存在争议。本研究旨在观察可溶性CD40配体(sCD40L)联合长春瑞滨对肺腺癌A549细胞的作用。方法以sCD40L处理A549细胞,MTT法和流式细胞仪检测CD40激发前后长春瑞滨作用下A549细胞的生长、细胞周期及凋亡率等生物学行为的变化,同时用Caspase-3检测试剂盒分析Caspase-3活性的改变。结果sCD40L对CD40分子的激发可增强长春瑞滨对表达CD40肺癌细胞株A549增殖的抑制率(P<0.05),但并不显著影响细胞周期时相和细胞凋亡率(P>0.05),Caspase-3活性反而显著下降(P<0.05)。结论以sCD40L激发CD40信号可增强肺腺癌细胞A549对长春瑞滨的敏感性,可能通过非凋亡的、Cas-pase非依赖性的机制,且可能与抑制细胞周期进程无关。 Background and objective The results of published data on the effect of CD40 signal related to cancer cell sensitivity to chemotherapy are inconclusive. The aim of this study is to investigate the effect of soluble CD40 ligand (sCD40L) combined with vinorelbine on lung adenocarcinoma cell line A549. Methods Lung adenocarcinoma A549 cells were chosen as target cells and CD40 signal was stimulated by sCD40L. MTT assay and flow cytometry were used to determine the changes of cell proliferation, cell cycle and apoptosis of A549 cells treated by vinorelbine after CD40 was stimulated. The activity of Caspase-3 was measured using Caspase-3 cellular activity assay kit plus. Results After CD40 stimulation, an increase of inhibition on CD40 positive cell line A549 proliferation was confirmed when vinorelbine was added (P0.05). However, no significant changes were shown in apoptosis and cell cycle (P0.05). On the other hand, the activity of Caspase-3 was substantially decreased (P0.05). Conclusion Stimulation of CD40 can increase lung adenocarcinoma cell line A549 sensitivity to vinorelbine, which may be through a non-apoptosis, Caspase independent mechanism, and not associated with the inhibition of cell cycle.
出处 《中国肺癌杂志》 CAS 2010年第7期686-690,共5页 Chinese Journal of Lung Cancer
基金 国家自然科学基金(No.30971320) 江苏省卫生厅医学科技发展基金(No.P200904) 江苏省"兴卫工程"医学重点人才基金(No.RC2007051)资助~~
关键词 可溶性CD40配体 长春瑞滨 肺肿瘤 sCD40L Vinorelbine Lung neoplasms
  • 相关文献

参考文献23

  • 1Loskog AS, Eliopoulos AG. The Janus faces of CD40 in cancer. Semin Immunol, 2009, 21(5): 301-307.
  • 2Vonderheide RH, Dutcher JP, Anderson JE, et al. Phase I study of recombinant human CD40 ligand in cancer patients.J Clin Oncol. 2001, 19(13): 3280-3287.
  • 3Forero-Torres A, Furman RR, Rosenblatt JD, et al. A humanized antibody against CD40 (SGN-40) is well tolerated and active in non-Hodgkin's lymphoma (NHL): results of a phase I study.J Clin Oncol, 2006, 24(185): 430s.
  • 4Vonderheide RH, Flaherty KT, Khalil M, et al. Clinical activity and immune modulation in cancer patients treated with CP-870, 893, a novel CD40 agonist monoclonal antibody. J Clin Oncol, 2007, 25 (7): 876-883.
  • 5Voorzanger-Rousselot N, Favrot MC, Blay JY. Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells. Blood, 1998, 92(9): 3381-3387.
  • 6Esteva FJ, Wang J, Lin E et al. CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.Breast Cancer Res, 2007, 9(6): R87.
  • 7Voorzanger-Rousselot N, Alberti L, BlayJY. CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways. BMC Cancer, 2006, 6: 75.
  • 8施勤,陈永井,谢芳,马泓冰,季玉红,於葛华,王勤,葛彦,张学光.rhCD40L联合化疗药物对乳腺癌细胞株生物学行为的影响[J].现代免疫学,2005,25(1):5-10. 被引量:6
  • 9王天立,黄建安,於葛华,雷伟,张学光.CD40信号对肺癌细胞化疗敏感性影响的实验研究[J].苏州大学学报(医学版),2004,24(2):127-129. 被引量:1
  • 10Young LS, Eliopoulos AG. TNF receptors and their ligands: in sickness and in health, in life and death. Curr Opin Pharmacol, 2004, 4(4): 311-313.

二级参考文献24

  • 1Van Kooten C,Banchereau J.Functional role of CD40 and its ligand[J].International Archives of Allergy &amp; Immunology,1997,113:393-399.
  • 2Alex W Tong,Marvin J Stone.Prospects for CD40-directed experimental therapy of human cancer[J].Cancer Gene Therapy,2003,10:1-13.
  • 3Yamada M,Shiroko T,Kawaguchi Y,et al.CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I,ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors[J].Int J Cancer,2001,92:589~599.
  • 4Eliopoulos AG,Davies C,Knox PG,et al.CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily[J].Mol Cell Biol,2000,20:5503-5515.
  • 5Okada Y,Kato M,Minakami H.Reduced expression of flice-inhibitory protein (FLIP) and NFkappaB is associated with death receptor-induced cell death in human aortic endothelial cells (HAECs)[J].Cytokine,2001,15:66~74
  • 6Cardoso AA, Schultze JL, Boussiotis VA, et al. Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen[J]. Blood, 1996,88:41-48.
  • 7Khanna R, Cooper L, Kienzle N, et al. Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells[J]. J Immunol, 1997,159:5782-6785.
  • 8Lillard JW Jr, Boyaka PN, Taub DD, et al. RANTES potentiates antigen-specific mucosal immune responses [J]. J Immunol, 2001,166:162-169.
  • 9Basok A, Shnaider A, Man L, et al. CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES [J]. J Am Soc Nephrol, 2001,12:695-702.
  • 10Propst SM, Denson R, Rothstein E, et al. Proinflammatory and Th2-derived cytokines modulate CD40-mediated expression of inflammatory mediators in airway epithelia: implications for the role of epithelial CD40 in airway inflammation [J]. J Immunol,2000,165:2214-2221.

共引文献18

同被引文献32

  • 1王天立,黄建安,於葛华,毛一香,王光杰,张学光.可溶性CD40配体对肺癌细胞A549的生物学作用及其机制研究[J].癌症,2004,23(11):1278-1282. 被引量:9
  • 2周平,王家银,关向丽,孙培玉.白细胞介素-6在急性髓系白血病中的表达及其意义[J].白血病.淋巴瘤,2005,14(1):33-33. 被引量:2
  • 3李娟,陈琦,任明强,冯永怀,高珍.急性髓细胞白血病血浆中sCD40L表达的研究[J].遵义医学院学报,2010,33(6):543-544. 被引量:2
  • 4吴剑卿,赵卫红,殷凯生,程蕴琳.腺相关病毒-CD40配体转导入肺癌细胞[J].中华肿瘤杂志,2007,29(4):253-257. 被引量:2
  • 5Loskog A,Totterman TH. CD40L-amultipotent molecule for tumor therapy[J].Endocr Metab Immune Disord Drug Targets,2007.23-28.
  • 6JablonskaE,Kiersnowska-Rogowska B,Rogowski F. TNF family molecules in the serum of patients with B-cell chronic lym-phocytic leukemia(B-CLL)[J].Leukemia and Lymphoma,2005.1307-1312.
  • 7Zhao Z,Yang P,Eckert RL. Caspase-8:a key role in the pathogenesis of diabetic embryopathy[J].Birth Defects Res B Dev Re-prod Toxicol,2009.72-77.
  • 8Odonkor CA,Achilefu S. Modulation of effector caspase cleavage determines response of breast and lung tumor cell lines to chemotherapy[J].Cancer Investigation,2009.417-429.
  • 9Tang W,Wang W,Zhang Y. Tumour necrosis factor-related apoptosis-inducing ligand(TRAIL)-induced chemokine release in both TRAIL-resistant and TRAIL-sensitive cells via nuclear factor kappa B[J].FEBS Journal,2009.581-593.
  • 10Asiem B ,Kiran R ,Shweta D ,et al. Current perspectives on the therapeutic aspects of chronic myelogenous leukemia[J]. Expert Opin Ther Patents, 2014,24(10) : 1117-1127.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部